Putnam Investments LLC Ptc Therapeutics, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 44,809 shares of PTCT stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,809

Previous 46,218 3.05%

Holding current value

$2 Million

Previous $1.04 Million 19.23%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $25,460 - $41,382	-1,409 Reduced 3.05%	44,809 $1.23 Million
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $8,986 - $16,837	-401 Reduced 0.86%	46,218 $1.04 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $63,549 - $92,964	-1,573 Reduced 3.26%	46,619 $1.9 Million
Q1 2023 May 22, 2023	SELL	$38.16 - $48.86 $464,597 - $594,870	-12,175 Reduced 20.17%	48,192 $2.33 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $726,695 - $1.19 Million	21,673 Added 56.01%	60,367 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $1.62 Million - $2.08 Million	38,694 New	38,694 $1.94 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $2.99 Million - $4.4 Million	-63,862 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $533,075 - $751,818	-11,115 Reduced 14.82%	63,862 $3.9 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $1.46 Million - $1.83 Million	-32,089 Reduced 29.97%	74,977 $3.51 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $742,714 - $959,455	17,451 Added 19.47%	107,066 $5.43 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $175,348 - $321,553	5,417 Added 6.43%	89,615 $4 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $2.71 Million - $4.22 Million	84,198 New	84,198 $4.04 Million

Others Institutions Holding PTCT

# of Institutions

226

Shares Held

78.7M

Call Options Held

135K

Put Options Held

220K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.19B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Ptc Therapeutics, Inc. Transaction History